AGAPE ATP CORPORATION Increase Decrease In Operating Lease Liability
AGAPE ATP CORPORATION (ATPC) reported Increase Decrease In Operating Lease Liability of -$80.26 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- AGAPE ATP CORPORATION increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$34.67K.
- AGAPE ATP CORPORATION increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$45.59K.
- AGAPE ATP CORPORATION increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$42.59K.
- AGAPE ATP CORPORATION increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$40.30K.
- AGAPE ATP CORPORATION increase decrease in operating lease liability for fiscal 2025 was -$159.76K.
- AGAPE ATP CORPORATION increase decrease in operating lease liability for fiscal 2024 was -$139.48K.
- AGAPE ATP CORPORATION increase decrease in operating lease liability for fiscal 2023 was -$147.95K.
- AGAPE ATP CORPORATION increase decrease in operating lease liability for fiscal 2022 was -$145.20K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$34.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$80.26K 10-Q · filed 2026-08-14 | -$122.85K derived: sum of 3 quarters · filed 2026-08-14 | -$163.14K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$45.59K 10-Q · filed 2026-05-15 | -$88.18K derived: sum of 2 quarters · filed 2026-05-15 | -$128.47K derived: sum of 3 quarters · filed 2026-05-15 | -$167.83K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$42.59K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$82.89K derived: sum of 2 quarters · filed 2026-04-13 | -$122.24K derived: sum of 3 quarters · filed 2026-08-14 | -$159.76K 10-K · filed 2026-04-13 |
| 2025-09-30 | -$40.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$79.65K derived: sum of 2 quarters · filed 2026-08-14 | -$117.17K 10-Q · filed 2025-11-13 | -$154.04K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$39.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$76.88K 10-Q · filed 2026-08-14 | -$113.75K derived: sum of 3 quarters · filed 2026-08-14 | -$150.47K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$37.52K 10-Q · filed 2026-05-15 | -$74.39K derived: sum of 2 quarters · filed 2026-05-15 | -$111.11K derived: sum of 3 quarters · filed 2026-05-15 | -$144.36K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$36.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$73.60K derived: sum of 2 quarters · filed 2026-04-13 | -$106.85K derived: sum of 3 quarters · filed 2026-04-13 | -$139.48K 10-K · filed 2026-04-13 |
| 2024-09-30 | -$36.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$69.97K derived: sum of 2 quarters · filed 2025-11-13 | -$102.61K 10-Q · filed 2025-11-13 | -$135.61K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$33.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$65.88K 10-Q · filed 2025-08-13 | -$98.89K derived: sum of 3 quarters · filed 2025-08-13 | -$134.28K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$32.63K 10-Q · filed 2025-05-15 | -$65.64K derived: sum of 2 quarters · filed 2025-05-15 | -$101.03K derived: sum of 3 quarters · filed 2025-05-15 | -$140.18K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$33.01K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$68.40K derived: sum of 2 quarters · filed 2025-03-31 | -$107.55K derived: sum of 3 quarters · filed 2025-03-31 | -$147.95K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$35.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$74.54K derived: sum of 2 quarters · filed 2024-11-14 | -$114.94K 10-Q · filed 2024-11-14 | -$153.42K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$39.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$79.55K 10-Q · filed 2024-08-14 | -$118.03K derived: sum of 3 quarters · filed 2024-08-14 | -$149.55K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$40.40K 10-Q · filed 2024-05-14 | -$78.88K derived: sum of 2 quarters · filed 2024-05-14 | -$110.40K derived: sum of 3 quarters · filed 2024-05-14 | -$146.61K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$38.48K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$70.00K derived: sum of 2 quarters · filed 2024-04-01 | -$106.21K derived: sum of 3 quarters · filed 2024-04-01 | -$145.20K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$31.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$67.73K derived: sum of 2 quarters · filed 2023-11-14 | -$106.72K 10-Q · filed 2023-11-14 | -$133.40K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$36.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$75.20K 10-Q · filed 2023-08-14 | -$101.88K derived: sum of 3 quarters · filed 2023-08-14 | -$138.94K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$38.99K 10-Q · filed 2023-05-15 | -$65.67K derived: sum of 2 quarters · filed 2023-05-15 | -$102.73K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$26.68K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$63.74K derived: sum of 2 quarters · filed 2023-03-31 | -$138.14K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$37.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$111.46K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$74.40K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |